Conmed

CNMD · NYSE

$47.58+$1.53 (+3.32%)TodayMarket closed ·
Prev close $46.05

Latest news

  • Press releaseBusiness Wire

    CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026

  • Press releaseBusiness Wire

    CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference

  • Press releaseBusiness Wire

    CONMED Corporation Reports Second Quarter 2026 Financial Results; Updates Full Year 2026 Guidance

  • Press releaseBusiness Wire

    CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal® Robotic Solution for Use with the Intuitive da Vinci 5 Hex Cannula

  • Press releaseBusiness Wire

    CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting

  • Press releaseBusiness Wire

    CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026

  • Press releaseBusiness Wire

    CONMED Corporation Appoints John E. Gallagher as Chief Financial Officer

  • Press releaseBusiness Wire

    CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors

  • News

    Conmed Q1 Adj. EPS $0.89 Beats $0.82 Estimate, Sales $317.046M Beat $310.507M Estimate

  • Press releaseBusiness Wire

    CONMED Corporation Announces First Quarter 2026 Financial Results

  • News

    Earnings Scheduled For April 29, 2026

  • Press releaseBusiness Wire

    CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026

  • News

    What Analysts Are Saying About Conmed Stock

  • Press releaseBusiness Wire

    CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results

  • News

    Earnings Scheduled For January 28, 2026

  • News

    A Glimpse of Conmed's Earnings Potential

  • Press releaseBusiness Wire

    CONMED Corporation Announces Chief Financial Officer Transition

  • Press releaseBusiness Wire

    CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference

  • Press releaseBusiness Wire

    CONMED Corporation to Announce Fourth Quarter 2025 Financial Results on January 28, 2026

  • NewsVandana Singh

    Conmed Dumps Gastroenterology Business To Focus On Core Surgical Markets

  • Press releaseBusiness Wire

    CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines

  • Press releaseBusiness Wire

    CONMED Corporation Announces Third Quarter 2025 Financial Results

  • Press releaseBusiness Wire

    CONMED Corporation to Announce Third Quarter 2025 Financial Results on November 5, 2025

  • Press releaseBusiness Wire

    CONMED Corporation Adds Kim Kelderman to its Board of Directors

  • Press releaseBusiness Wire

    CONMED Corporation Announces Quarterly Cash Dividend

  • Press releaseBusiness Wire

    CONMED Corporation Announces Second Quarter 2025 Financial Results

  • Press releaseBusiness Wire

    Martha Aronson to Step Down from CONMED Board of Directors Following Appointment as President and Chief Executive Officer of Merit Medical Systems, Inc.

  • Press releaseBusiness Wire

    CONMED Corporation to Announce Second Quarter 2025 Financial Results on July 30, 2025

  • News

    Demystifying Conmed: Insights From 5 Analyst Reviews

  • Press releaseBusiness Wire

    CONMED Corporation Appoints LaVerne Council as Chair of the Board of Directors

  • Press releaseBusiness Wire

    CONMED Corporation Announces Quarterly Cash Dividend

  • NewsAvi Kapoor

    CVS Health Posts Better-Than-Expected Earnings, Joins CommScope, Microsoft, Meta, Chart Industries, And Other Big Stocks Moving Higher On Thursday

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • News

    Breaking Down Conmed: 6 Analysts Share Their Views

  • Press releaseBusiness Wire

    CONMED Corporation Announces Leadership Succession

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.